Update on fingolimod Phase 3 trial in primary progressive MS

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Update on fingolimod Phase 3 trial in primary progressive MS

Post by MSUK »

Novartis announced today that the Phase III INFORMS study in primary progressive multiple sclerosis (PPMS) did not show a significant difference between fingolimod and placebo on a combination of disability measures. The safety results were consistent with the well-characterized safety profile of fingolimod in relapsing MS (RMS)....... Read more - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
Top
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Gilenya”